Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC)

NCT03747744 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitair Ziekenhuis Brussel